Log In
Thursday 26th November 2015

GSK's HIV drug matches Merck

2nd April 2012

A new once-daily HIV drug developed by GSK is as good as Merck's twice-daily rival.

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2015